Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure

Blood Pressure

Volumn 7, Issue 1, 1998, Pages 19-23

  Letizia, C ^a,b   De Toma, G ^a   Cerci, S ^a   Massa, R ^a   Coassin, S ^a   Subioli, S ^a   Scuro, L ^a   De Ciocchis, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Adrenomedullin; Primary aldosteronism

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; POTASSIUM; RENIN; SODIUM;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TOMOGRAPHY;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENOMEDULLIN; ADULT; BLOOD PRESSURE; ELECTROLYTES; FEMALE; HEMODYNAMIC PROCESSES; HORMONES; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PEPTIDES; POSTOPERATIVE PERIOD; REFERENCE VALUES;

EID: 0031906213     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370598437529     Document Type: Article

References (17)

1. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-60.
2. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6-10.
3. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-6.
4. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe T, Nakajima K, Sakakibara S, Marumo F. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226-30.
5. Kitamura K, Ichiki Y, Tanaka M et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288-90.
6. Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi EV. Adrenomedullin in pregnancy (Letter). Lancet 1997; 349: 328.
7. Meeram K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Bloom SR. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997; 82: 95-100.
8. Ishiyama Y, Kitamura K, Ichiki Y et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993; 241: 271-3.
9. Hirata Y, Hayakawa H, Suzuki Y et al. Mechanism of adrenomedullin-induced vasodilatation in the rat kidney. Hypertension 1995; 25 (Part 2): 790-5.
10. Kohno N, Hanehira T, Kano H et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102-7.
11. Nishikimi T, Kitamura K, Saito Y et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600-4.
12. Kato J, Kitamura K, Kuwasako K et al. Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens 1995; 8: 997-1000.
13. Jamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. Inhibition of aldosterone production by adrenomedullin, a hypertensive peptide, in the rat. Hypertension 1996; 28: 308-14.
14. Gordon RD. Primary aldosteronism. J Endocrinol Invest 1995; 18: 495-511.
15. Van RC, Adkins SD, Samson WK. Renal effects of adrenomedullin in the rat. PSEBM 1996; 211: 178-83.
16. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995; 25: 1185-90.
17. Letizia C, De Toma G, Cerci S et al. Plasma endothelin-1 levels in patients with aldosterone-producing adenoma and pheochromocytoma. Clin Exp Hypertens 1996; 18: 921-31.